NXGLHealthcare · Medical Instruments & SuppliesNXGL Stock Forecast: NexGel, Inc. Price Predictions for 2026-2027
The 1 Wall Street analysts covering NexGel, Inc. hold a median 12-month price target of $2 — +426.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 17 of 100 as at 22 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.
NXGL stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores NexGel, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (98): Smaller than most of the companies we track.
Momentum (5): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
NXGL stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on NXGL, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +426.3% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 12 Mar 2026 | Maxim Group | Maintains | Buy | $6.00 → $2.00 |
| 25 Feb 2022 | Maxim Group | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NXGL appears on the weeks it earns a place.
NXGL vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 24 Aug 2026, NexGel, Inc. returned −83.6% against +19.6% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
NXGL analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
NexGel, Inc. (NXGL) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −1.0×
- Price / sales
- 0.3×
- Price / book
- 0.8×
- EV / EBITDA
- −2.7×
Cheaper than 82% of US stocks
Cheaper than 89% of US stocks
Cheaper than 79% of US stocks
Cheaper than 73% of US stocks
- Revenue growth (YoY)
- 27.8%
- Earnings growth (YoY)
- −5.6%
- Gross margin
- 40.0%
- Operating margin
- −68.0%
- Net margin
- −51.3%
Higher than 77% of US stocks
Higher than 29% of US stocks
Higher than 50% of US stocks
Higher than 15% of US stocks
Higher than 10% of US stocks
- Return on equity
- −115.1%
- Return on assets
- −18.7%
- Dividend yield
- —
Higher than 12% of US stocks
Higher than 20% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
NexGel, Inc. (NXGL) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
NexGel, Inc. has a market value of $3.7M and an enterprise value of $11.4M.
Revenue in the twelve months to 31 Mar 2026: $11.3M. The latest quarter grew 27.8% year on year.
Net income over the same four quarters: −$3.1M, a −27.4% net margin.
Free cash flow in the twelve months to 31 Mar 2026: −$1.5M.
Trailing P/E: −1.0×; forward P/E: 0.9× — the forward figure prices analyst consensus estimates, not reported earnings.
NexGel, Inc. employs 19 people — $593K of revenue per employee.
Data provided by Twelve Data
NXGL vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own NexGel, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about NXGL stock
What is the NXGL stock price forecast for 2026-2027?
The 1 Wall Street analysts covering NexGel, Inc. have a median 12-month price target of $2, with estimates ranging from $2 to $2. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is NXGL stock a buy right now?
Of the 1 analysts covering NexGel, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NexGel, Inc. 17 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank NXGL?
As at 22 Aug 2026, NexGel, Inc. ranks 17 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (98 of 100).
Will NXGL stock go up?
No one can know that. What the data says: the median 12-month target from 1 analysts implies +426.3% from the last close, and Ticker Nerd's factor model ranks NexGel, Inc. 17 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the NXGL stock forecast for 2030?
No analyst covering NexGel, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NXGL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2 to $2 over the next 12 months.
How has NXGL stock performed over the past year?
NexGel, Inc. returned -83.6% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does NexGel, Inc. do?
NexGel Inc. is a specialty healthcare company that manufactures and sells high water content, electron beam cross-linked aqueous polymer hydrogels and gels primarily for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
About NexGel, Inc.
NexGel Inc. is a specialty healthcare company that manufactures and sells high water content, electron beam cross-linked aqueous polymer hydrogels and gels primarily for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: NexGel, focused on producing ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, and CG labs. The company provides over-the-counter remedy solutions including blister and pain applications, alongside beauty and cosmetic solutions. NexGel Inc. also engages in contract manufacturing and maintains a portfolio of branded consumer products in health, wellness, and beauty categories. Recent initiatives include partnerships for launching enzyme supplements and acquisitions of international beauty brands to expand its consumer offerings. Additionally, it develops innovative products such as NEXDrape, an incise surgical drape for patients with impaired skin, and NEXDerm, an adhesive tape for securing medical devices. Founded in 2007 and headquartered in Langhorne, Pennsylvania, NexGel Inc. plays a key role in advancing hydrogel-based solutions across medical and personal care markets.
CEO Mr. Adam R. Levy · 19 employees · United States · https://nexgel.com